January 20, 2024

Fol­low­ing her con­vic­tion on fraud charges, for­mer Ther­a­nos CEO Eliz­a­beth Holmes has been ex­clud­ed from par­tic­i­pat­ing in fed­er­al health­care pro­grams — in­clud­ing Medicare and Med­ic­aid

The Cannes Li­ons fes­ti­val and award show an­nounced that Dentsu Health’s Col­lette Douai­hy will lead the phar­ma ju­ry and Edel­man’s Wendy Chan will head up

Sen. Amy Klobuchar (D-MN) is pres­sur­ing six phar­ma com­pa­nies to re­move im­prop­er­ly list­ed patents from the FDA’s Or­ange Book by the end of the month,

Lund­beck is tak­ing a new tack in its mi­graine mar­ket­ing for Vyep­ti, the on­ly IV-in­fused op­tion in the crowd­ed mar­ket. The cam­paign, launched this week,

Ike­na On­col­o­gy is cut­ting 35% of its work­ers to help fund two on­col­o­gy can­di­dates af­ter dump­ing two oth­er can­cer as­sets it was slat­ed to work

PMV Phar­ma­ceu­ti­cals to cut 30% of its em­ploy­ees: The Prince­ton, NJ-based com­pa­ny had 62 full-time em­ploy­ees as of Feb. 28. It ex­pects the cuts to ex­tend

De­spite cau­tious op­ti­mism in bio­phar­ma cir­cles about 2024, there’s emerg­ing think­ing that such sen­ti­ment is not guar­an­teed to trans­late in­to ma­te­r­i­al gains. The Fed­er­al Re­serve’s

An “off-the-shelf” cell ther­a­py en­gi­neered us­ing nat­ur­al killer cells re­sult­ed in last­ing re­spons­es in a small clin­i­cal tri­al for cer­tain lym­phomas and leukemia, ac­cord­ing to

In­cred­i­ble Health, a job mar­ket­place plat­form for nurs­es val­ued at $1.65 bil­lion, has laid off staff this month, End­points News has learned. The job cuts

A for­mer Pfiz­er em­ploy­ee was found guilty of buy­ing stock op­tions a day be­fore the com­pa­ny un­veiled pos­i­tive Covid-19 drug da­ta. Amit Da­gar was a